We know that obesity is well-established as an obesity-associated cancer risk factor
Its quite complex, and it actually needs multifaceted care, just like what we talk about with type 2 diabetes or heart disease as an example
Using FDA-approved prescription weight loss medications, such as GLP-1 agonists, Trava Health helps people with obesity and related health conditions like cardiovascular disease and type 2 diabetes achieve their weight loss goals
Rosenstock et al., NEJM 2023), retatrutide begins to produce measurable effects on body weight and glycaemic markers within the first two to four weeks of treatment
Essential micronutrient iron coordinates several cellular functions, including proliferation, metabolic activity, and cellular differentiation
Practical considerations make this combination challenging for some individuals